While cross-trial comparisons come with important caveats patient populations, trial designs, and dose titrations all differ the overall pattern is clear
Let's examine how these factors can slow your progress and what you can do about it
Two initial studies showed a significant difference in retained gastric contents, with there being ~524% retained gastric contents in GLP-1RA users compared to non-users (13, 14)
Youll have more information about your progress and can often maintain your motivation
The science behind the patch Transdermal patches are widely used in healthcare for pain-free, controlled, or consistent drug delivery
That single figure from RepData research fielded on behalf of PepsiCo, explains why protein feels less like a trend and more like a requirement